Login | Register

First pre-surgery breast cancer drug approved by FDA

The US Food and Drug Administration (FDA) has approved the first drug to be used in early stage breast cancer treatment. Perjeta (pertuzumab) will be used as part of a complete treatment regimen for patients before surgery (neoadjuvant setting)...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *